Interleukin-6 is a prognostic factor in multiple myeloma [letter] [see comments]H. Ludwig, Heidemarie Huber, DM Nachbaur et al.|Blood|1991Cited by 142
Multiple myeloma (MM) with deletion of 13q13 is characterized by increased bone marrow (BM) neovascularization - Implications for treatment of high-risk disease.Johannes Drach, Heidemarie Huber, J Ackermann et al.|Queensland's institutional digital repository (The University of Queensland)|1999Cited by 0